Abstract
Spinal cord injury (SCI) triggers a sequel of events commonly associated with cell death and dysfunction of glias and neurons surrounding the lesion. Although astrogliosis and glial scar formation have been involved in both damage and repair processes after SCI, their role remains controversial. Our goal was to investigate the effects of the P2 receptors antagonists, PPADS and suramin, in the establishment of the reactive gliosis and the formation of the glial scar. Molecular biology, immunohistochemistry, spared tissue, and locomotor behavioral studies were used to evaluate astrogliosis, in adult female Sprague–Dawley rats treated with P2 antagonists after moderate injury with the NYU impactor device. Semi-quantitative RT-PCR confirmed the presence of P2Y1, P2Y2, P2Y4, P2Y6, P2Y12, and P2X2 receptors in the adult spinal cord. Immunohistochemistry studies confirmed a significant decrease in GFAP-labeled cells at the injury epicenter as well as a decrease in spared tissue after treatment with the antagonists. Functional open field testing revealed no significant locomotor score differences between treated and control animals. Our work is consistent with studies suggesting that astrogliosis is an important event after SCI that limits tissue damage and lesion spreading.
Similar content being viewed by others
References
Abbracchio MP, Saffrey MJ, Hopker V, Burnstock G (1994) Modulation of astroglial cell proliferation by analogues of adenosine and ATP in primary cultures of rat striatum. Neuroscience 59:67–76
Abbracchio MP, Burnstock G, Boeynaems JM et al (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58:281–341
Basso DM, Beattie MS, Bresnahan JC (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12:1–21
Becker T, Anliker B, Becker CG et al (2000) Tenascin-R inhibits regrowth of optic fibers in vitro and persists in the optic nerve of mice after injury. Glia 29:330–346
Burnstock G (1997) The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology 36:1127–1139
Burnstock G (2000) P2X receptors in sensory neurones. Br J Anaesth 84:476–488
Bush TG, Puvanachandra N, Horner CH et al (1999) Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23:297–308
Cafferty WB, Yang SH, Duffy PJ, Li S, Strittmatter SM (2007) Functional axonal regeneration through astrocytic scar genetically modified to digest chondroitin sulfate proteoglycans. J Neurosci 27:2176–2185
Cavaliere F, Florenzano F, Amadio S et al (2003) Up-regulation of P2X2, P2X4 receptor and ischemic cell death: prevention by P2 antagonists. Neuroscience 120:85–98
Charlton SJ, Brown CA, Weisman GA, Turner JT, Erb L, Boarder MR (1996) PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors. Br J Pharmacol 118:704–710
Chiu FC, Goldman JE (1985) Regulation of glial fibrillary acidic protein (GFAP) expression in CNS development and in pathological states. J Neuroimmunol 8:283–292
Collo G, North RA, Kawashima E et al (1996) Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci 16:2495–2507
Cruz-Orengo L, Figueroa JD, Velazquez I et al (2006) Blocking EphA4 upregulation after spinal cord injury results in enhanced chronic pain. Exp Neurol 202:421–433
Di Prospero NA, Zhou XR, Meiners S, McAuliffe WG, Ho SY, Geller HM (1998) Suramin disrupts the gliotic response following a stab wound injury to the adult rat brain. J Neurocytol 27:491–506
Dijkstra S, Geisert EE Jr, Dijkstra CD, Bar PR, Joosten EA (2001) CD81 and microglial activation in vitro: proliferation, phagocytosis and nitric oxide production. J Neuroimmunol 114:151–159
Ducker TB, Kindt GW, Kempf LG (1971) Pathological findings in acute experimental spinal cord trauma. J Neurosurg 35:700–708
Erb L, Liao Z, Seye CI, Weisman GA (2006) P2 receptors: intracellular signaling. Pflugers Arch 452:552–562
Fam SR, Gallagher CJ, Salter MW (2000) P2Y(1) purinoceptor-mediated Ca(2+) signaling and Ca(2+) wave propagation in dorsal spinal cord astrocytes. J Neurosci 20:2800–2808
Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV (2004) Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 24:2143–2155
Ferrari D, Chiozzi P, Falzoni S et al (1997) ATP-mediated cytotoxicity in microglial cells. Neuropharmacology 36:1295–1301
Fields RD, Burnstock G (2006) Purinergic signalling in neuron–glia interactions. Nat Rev Neurosci 7:423–436
Fields RD, Stevens-Graham B (2002) New insights into neuron–glia communication. Science 298:556–562
Figueroa JD, Benton RL, Velazquez I et al (2006) Inhibition of EphA7 up-regulation after spinal cord injury reduces apoptosis and promotes locomotor recovery. J Neurosci Res 84:1438–1451
Fitch MT, Silver J (1997) Glial cell extracellular matrix: boundaries for axon growth in development and regeneration. Cell Tissue Res 290:379–384
Fitch MT, Doller C, Combs CK, Landreth GE, Silver J (1999) Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J Neurosci 19:8182–8198
Fournier AE, Strittmatter SM (2001) Repulsive factors and axon regeneration in the CNS. Curr Opin Neurobiol 11:89–94
Franke H, Illes P (2006) Involvement of P2 receptors in the growth and survival of neurons in the CNS. Pharmacol Ther 109:297–324
Franke H, Krugel U, Schmidt R, Grosche J, Reichenbach A, Illes P (2001) P2 receptor-types involved in astrogliosis in vivo. Br J Pharmacol 134:1180–1189
Franke H, Krugel U, Illes P (2006) P2 receptors and neuronal injury. Pflugers Arch 452:622–644
Franke H, Sauer C, Rudolph C, Krügel U, Hengstler JG, Illes P (2009) P2 receptor-mediated stimulation of the PI3-K/Akt-pathway in vivo. Glia 57:1031–1045
Gordon JL (1986) Extracellular ATP: effects, sources and fate. Biochem J 233:309–319
Hansson E, Ronnback L (2003) Glial neuronal signaling in the central nervous system. FASEB J 17:341–348
Haydon PG (2001) GLIA: listening and talking to the synapse. Nat Rev Neurosci 2:185–193
Hulsebosch CE (2002) Recent advances in pathophysiology and treatment of spinal cord injury. Adv Physiol Educ 26:238–255
Iannotti C, Zhang YP, Shields LB et al (2006) Dural repair reduces connective tissue scar invasion and cystic cavity formation after acute spinal cord laceration injury in adult rats. J Neurotrauma 23:853–865
Irizarry-Ramirez M, Willson CA, Cruz-Orengo L et al (2005) Upregulation of EphA3 receptor after spinal cord injury. J Neurotrauma 22:929–935
Jacobson KA, Ivanov AA, de Castro S, Harden TK, Ko H (2009) Development of selective agonists and antagonists of P2Y receptors. Purinergic Signal 5:75–89
Kato S, Gondo T, Hoshii Y, Takahashi M, Yamada M, Ishihara T (1998) Confocal observation of senile plaques in Alzheimer's disease: senile plaque morphology and relationship between senile plaques and astrocytes. Pathol Int 48:332–340
Kharlamov A, Jones SC, Kim DK (2002) Suramin reduces infarct volume in a model of focal brain ischemia in rats. Exp Brain Res 147:353–359
Kobayashi K, Fukuoka T, Yamanaka H et al (2006) Neurons and glial cells differentially express P2Y receptor mRNAs in the rat dorsal root ganglion and spinal cord. J Comp Neurol 498:443–454
Laird MD, Vender JR, Dhandapani KM (2008) Opposing roles for reactive astrocytes following traumatic brain injury. Neurosignals 16:154–164
Lambrecht G, Braun K, Damer M et al (2002) Structure–activity relationships of suramin and pyridoxal-5′-phosphate derivatives as P2 receptor antagonists. Curr Pharm Des 8:2371–2399
Laping NJ, Teter B, Nichols NR, Rozovsky I, Finch CE (1994) Glial fibrillary acidic protein: regulation by hormones, cytokines, and growth factors. Brain Pathol 4:259–275
Lazarowski ER, Homolya L, Boucher RC, Harden TK (1997) Direct demonstration of mechanically induced release of cellular UTP and its implication for uridine nucleotide receptor activation. J Biol Chem 272:24348–24354
McGraw J, Hiebert GW, Steeves JD (2001) Modulating astrogliosis after neurotrauma. J Neurosci Res 63:109–115
McKerracher L, David S, Jackson DL, Kottis V, Dunn RJ, Braun PE (1994) Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 13:805–811
Merkler D, Metz GA, Raineteau O, Dietz V, Schwab ME, Fouad K (2001) Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J Neurosci 21:3665–3673
Miranda JD, White LA, Marcillo AE, Willson CA, Jagid J, Whittemore SR (1999) Induction of Eph B3 after spinal cord injury. Exp Neurol 156:218–222
Myer DJ, Gurkoff GG, Lee SM, Hovda DA, Sofroniew MV (2006) Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 129:2761–2772
Nakamura M, Bregman BS (2001) Differences in neurotrophic factor gene expression profiles between neonate and adult rat spinal cord after injury. Exp Neurol 169:407–415
Neary JT, Baker L, Jorgensen SL, Norenberg MD (1994) Extracellular ATP induces stellation and increases glial fibrillary acidic protein content and DNA synthesis in primary astrocyte cultures. Acta Neuropathol 87:8–13
Neary JT, Rathbone MP, Cattabeni F, Abbracchio MP, Burnstock G (1996) Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci 19:13–18
Okada S, Nakamura M, Mikami Y et al (2004) Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury. J Neurosci Res 76:265–276
Park E, Velumian AA, Fehlings MG (2004) The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 21:754–774
Pasterkamp RJ, Anderson PN, Verhaagen J (2001) Peripheral nerve injury fails to induce growth of lesioned ascending dorsal column axons into spinal cord scar tissue expressing the axon repellent Semaphorin3A. Eur J Neurosci 13:457–471
Peng W, Cotrina ML, Han X et al (2009) Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc Natl Acad Sci USA 106:12489–12493
Popovich PG, Guan Z, Wei P, Huitinga I, van Rooijen N, Stokes BT (1999) Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol 158:351–365
Popovich PG, van Rooijen N, Hickey WF, Preidis G, McGaughy V (2003) Hematogenous macrophages express CD8 and distribute to regions of lesion cavitation after spinal cord injury. Exp Neurol 182:275–287
Rathbone MP, Middlemiss PJ, Gysbers JW et al (1999) Trophic effects of purines in neurons and glial cells. Prog Neurobiol 59:663–690
Rodriguez-Zayas AE, Torrado AI, Miranda JD (2010) P2Y2 receptor expression is altered in rats after spinal cord injury. Int J Dev Neurosci 28:413–421
Santiago JM, Rosas O, Torrado AI, Gonzalez MM, Kalyan-Masih PO, Miranda JD (2009) Molecular, anatomical, physiological, and behavioral studies of rats treated with buprenorphine after spinal cord injury. J Neurotrauma 26:1783–1793
Scemes E, Suadicani SO, Spray DC (2000) Intercellular communication in spinal cord astrocytes: fine tuning between gap junctions and P2 nucleotide receptors in calcium wave propagation. J Neurosci 20:1435–1445
Schnell L, Schwab ME (1990) Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 343:269–272
Sidoryk-Wegrzynowicz M, Wegrzynowicz M, Lee E, Bowman A, Aschner M (2010) Role of astrocytes in brain function and disease. Toxicol Pathol 39(1):115–123
Sinescu C, Popa F, Grigorean VT et al (2010) Molecular basis of vascular events following spinal cord injury. J Med Life 3:254–261
Skaper SD, Facci L, Culbert AA et al (2006) P2X(7) receptors on microglial cells mediate injury to cortical neurons in vitro. Glia 54:234–242
Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119:7–35
Tanhoffer RA, Yamazaki RK, Nunes EA et al (2007) Glutamine concentration and immune response of spinal cord-injured rats. J Spinal Cord Med 30:140–146
Tompkins JD, Parsons RL (2006) Exocytotic release of ATP and activation of P2X receptors in dissociated guinea pig stellate neurons. Am J Physiol Cell Physiol 291:C1062–C1071
Wang X, Arcuino G, Takano T et al (2004) P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 10:821–827
Washburn KB, Neary JT (2006) P2 purinergic receptors signal to STAT3 in astrocytes: difference in STAT3 responses to P2Y and P2X receptor activation. Neuroscience 142:411–423
Weisman GA, Wang M, Kong Q et al (2005) Molecular determinants of P2Y2 nucleotide receptor function: implications for proliferative and inflammatory pathways in astrocytes. Mol Neurobiol 31:169–183
Widenfalk J, Lundstromer K, Jubran M, Brene S, Olson L (2001) Neurotrophic factors and receptors in the immature and adult spinal cord after mechanical injury or kainic acid. J Neurosci 21:3457–3475
Williams A, Piaton G, Lubetzki C (2007) Astrocytes—friends or foes in multiple sclerosis? Glia 55:1300–1312
Willson CA, Irizarry-Ramirez M, Gaskins HE et al (2002) Upregulation of EphA receptor expression in the injured adult rat spinal cord. Cell Transplant 11:229–239
Zhang D, Hu X, Qian L, O’Callaghan JP, Hong JS (2010) Astrogliosis in CNS pathologies: is there a role for microglia? Mol Neurobiol 41:232–241
Zimmermann H (2006) Nucleotide signaling in nervous system development. Pflugers Arch 452:573–588
Acknowledgements
The authors thank Luz C. Arocho and Laurivette Mosquera for the excellent technical assistance during surgeries and post-operatory procedures. Special thanks also to the personnel of the Animal Resources Center (University of Puerto Rico, Medical Science Campus) and the Experimental Surgery facilities. Our gratitude to Jose O. Garcia, Ph.D. for his critiques in the manuscript. This work was in partial fulfillment of Ana E. Rodríguez-Zayas doctoral dissertation and was supported by NIH-MRISP (2 R24 MH 48190–14), NIH-SNRP (NS39405), MBRS- SCORE (S06-GM008224), MBRS-RISE (GM-68138) and the Associated Deanship of Biomedical Sciences and Graduate Studies of the UPR School of Medicine. Editorial support was provided by Dr. Mary Helen Mays, Puerto Rico Clinical and Translational Research Consortium, funded by the National Center for Research Resources (NCRR) (1U54RR026139-01A1), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rodríguez-Zayas, A.E., Torrado, A.I., Rosas, O.R. et al. Blockade of P2 Nucleotide Receptors After Spinal Cord Injury Reduced the Gliotic Response and Spared Tissue. J Mol Neurosci 46, 167–176 (2012). https://doi.org/10.1007/s12031-011-9567-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-011-9567-6